
List of Neuromuscular blocking agents - Drugs.com
Compare neuromuscular blocking agents. View important safety information, ratings, user reviews, popularity and more.
Neuromuscular-blocking drug - Wikipedia
Neuromuscular-blocking drugs, or Neuromuscular blocking agents (NMBAs), block transmission at the neuromuscular junction, [1] causing paralysis of the affected skeletal muscles. This is accomplished via their action on the post-synaptic acetylcholine (Nm) receptors.
Neuromuscular Blocking Agents - StatPearls - NCBI Bookshelf
Jun 8, 2024 · The widespread adoption of neuromuscular blocking agents (NMBAs), or drugs (NMBDs), significantly impacted the field of anesthesia. Before the introduction of NMBAs, anesthesia was induced and maintained with intravenous and inhalational agents.
Neuromuscular blocking agents: Uses, common brands, and
Apr 5, 2022 · What are Neuromuscular blocking agents? Although a startling concept, the neuromuscular blocking agent (NMBA) drug class is used to induce complete muscle paralysis within seconds to minutes.
Neuromuscular Blocking Agents: Use and Controversy in the …
Jan 19, 2017 · Neuromuscular blocking agents (NMBAs) play an important role in the management of a large number of hospital patients. In addition to their routine use in surgical anesthesia, NMBAs may be valuable in many new and evolving critical care situations.
Neuromuscular Blocking Agents: An Overview (2025)
Feb 4, 2025 · Neuromuscular blocking agents (NMBAs) are a class of drugs that prevent nerve impulses from reaching muscles, effectively causing temporary paralysis of the skeletal muscles.
UpToDate
Neuromuscular blocking agents (NMBAs) are usually administered during anesthesia to facilitate endotracheal intubation and/or to improve surgical conditions. NMBAs may decrease the incidence of hoarseness and vocal cord injuries during intubation, and can facilitate mechanical ventilation in patients with poor lung compliance [1-5].
Nondepolarizing Neuromuscular Blockers - StatPearls - NCBI Bookshelf
Oct 18, 2024 · Nondepolarizing neuromuscular blockers (nNMBs) are used as primary therapy to facilitate endotracheal intubation and as adjuvant therapy for maintaining anesthesia and managing critically ill patients.
Neuromuscular blocking agents in the intensive care unit - PMC
Neuromuscular blocking agents (NMBA) are drugs that affect the motor endplate of striated muscles 1 by blocking the transmission of nerve impulses at the neuromuscular junction.
Neuromuscular Blocking Agents General Statement (Monograph) - Drugs.com
Neuromuscular blocking agents are drugs that cause skeletal muscle relaxation and are classified as depolarizing or nondepolarizing (competitive) agents. Neuromuscular blocking agents are used to produce skeletal muscle relaxation during surgery after general anesthesia has been induced.